The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

Dr Temitope Ilori, the Director-General of the National Agency for the Control of AIDS (NACA), says plans are on to begin ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

The future of PEPFAR, the U.S. government's global effort to combat HIV/AIDS, has been called into question amid a broader ...

Researchers at the University of Massachusetts Amherst have quantified the impacts of a constellation of social factors on ...

Macrophages, like CD4 + T cells, serve as the primary target cells for HIV and facilitate in the virus’s dissemination throughout the body. HIV infection significantly alters the body’s immune ...

If left untreated, human immunodeficiency virus (HIV) almost always will progress to AIDS, even after many years. The immune defenses become compromised and the body is less able to defend itself ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Regensburg has unveiled insights into how HIV-1, the virus responsible ...

She is among a number of people with HIV who are taking part in a HSE campaign to address misconceptions around the virus and help reduce the stigma associated with it. The couple married five ...